Syed Ali, MD
Dermatology · West Hills, CANPI 1821165143
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $151,772 of the $182,655 with a category attached, or 83.1%. 35 manufacturers reported payments, led by Johnson & Johnson at 46.1% of the total. Among dermatology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,228 payments — averaging $148.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$84K
- Pfizer$45K
- Incyte Corporation$41K
- Mayne Pharma Commercial LLC$2K
- AbbVie$2K
- Galderma Laboratories, L.p.$1K
- plus $8K from 29 others
Across 269 payments — averaging $4132.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$362K
- AbbVie$176K
- Pfizer$121K
- GSK$115K
- E.r. Squibb & Sons, L.L.C.$87K
- Sun Pharmaceutical Industries Inc.$54K
- plus $197K from 8 others
What the payments were for
- Consulting fees$1,6501%
- Speaking & faculty fees$151,77283%
- Travel & lodging$7,9204%
- Food & beverage$20,75111%
- Education$5610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 216 | $84,182 |
| Pfizer | 95 | $44,801 |
| Incyte Corporation | 109 | $40,938 |
| Mayne Pharma Commercial LLC | 206 | $2,248 |
| AbbVie(2 entities) | 127 | $1,847 |
| Galderma Laboratories, L.p. | 87 | $1,120 |
| Amgen | 58 | $1,094 |
| UCB, Inc. | 44 | $1,041 |
| Novartis | 34 | $835 |
| Lilly USA, LLC | 43 | $765 |
| Sun Pharmaceutical Industries Inc. | 28 | $587 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 49 | $583 |
| Regeneron Healthcare Solutions, Inc. | 18 | $555 |
| Arcutis Biotherapeutics, Inc. | 33 | $455 |
| LEO Pharma Inc. | 20 | $389 |
| E.r. Squibb & Sons, L.L.C. | 18 | $257 |
| Stryker | 1 | $169 |
| Sanofi | 5 | $169 |
| Almirall LLC | 8 | $132 |
| Paratek Pharmaceuticals, Inc. | 5 | $88 |
| Merz North America, Inc. | 4 | $81 |
| Merck | 4 | $50 |
| Nabriva Therapeutics, PLC | 3 | $47 |
| Boehringer Ingelheim | 1 | $27 |
| Dermira, Inc. | 1 | $24 |
| LNHC, Inc | 1 | $24 |
| Mylan Pharmaceuticals Inc. | 2 | $24 |
| Botanix SB Inc | 1 | $23 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $18 |
| EPI Health, LLC | 1 | $16 |
| Revance Therapeutics, Inc. | 1 | $14 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $12 |
| VYNE Pharmaceuticals Inc. | 1 | $11 |
| Kerecis Limited | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$182,655 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bimzelx AutoinjectorBimekizumab-Bkzx | 20 | $290,202 |
| Tacrolimus | 30 | $5,717 |
| Clobetasol Propionate | 121 | $4,085 |
| Doxycycline Monohydrate | 88 | $3,456 |
| Ketoconazole | 136 | $1,853 |
| Clindamycin Phosphate | 25 | $988 |
| Minocycline Hcl | 37 | $859 |
| Tretinoin | 20 | $614 |
| Doxycycline Hyclate | 25 | $473 |
| Triamcinolone Acetonide | 38 | $438 |
| Minoxidil | 52 | $315 |
| Nystatin | 21 | $207 |
| Terbinafine Hcl | 21 | $139 |
| Celecoxib | 11 | $110 |
| Prednisone | 35 | $97 |
Paid to pharmacies, not to this prescriber.
Other dermatology in West Hills
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Raja SivamaniSacramento$1.9M
- Tien NguyenFountain Valley$1.2M
- Tina BhutaniSan Francisco$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.